Integrated R&D Services

Get Free Quote

* Name

Phone

* Email

* Products/Services Interested

Project Description

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

IVD R&D Services in Gastroenterology and Hepatology

Inquiry

Ace Therapeutics is committed to advancing the development of in vitro diagnostic (IVD) tools and technologies, with a specific focus on designing and validating innovative solutions that facilitate the detection of various gastrointestinal and liver conditions. Our experts excel at providing customized diagnostic solutions, encompassing molecular assays, biomarker detection platforms, and specialized imaging techniques specifically tailored to address the intricacies of these disease areas.

Types of IVD Technologies We Can Develop

Biochemical diagnostic materials and assays

Biochemical Diagnostic Technology Development

We specialize in providing comprehensive services in the field of development and validation of biochemical diagnostic tools for the analysis and detection of specific biochemical parameters relevant to gastrointestinal and liver diseases, such as the development of enzyme activity assay kits and reagents for the quantification of specific metabolites boxes, providing customers with valuable insights into product development and optimization.

Immunodiagnostic Technology Development

Our team specializes in helping customers develop immunodiagnostic technologies that harness immune responses to detect and quantify disease-specific markers. For example, for specific antibodies or antigen markers, we can help customers develop antibodies with specific chromophores or fluorescent groups for enzyme-linked immunosorbent assay (ELISA) and immunofluorescence assays to detect targets accurately and sensitively.

Molecular Diagnostic Technology Development

At Ace Therapeutics, our highly skilled molecular diagnostic specialists can build precise assays like PCR (polymerase chain reaction) and NGS (next-generation sequencing) panels for your targeted application. By leveraging our extensive discovery expertise in omics technologies and years of experience in diagnostic assay development and validation, we aim to efficiently design and optimize molecular diagnostic tools to provide you with genomic, transcriptomic and protein biomarker findings.

Diagnostic Imaging Technology Development

At Ace Therapeutics, we offer a comprehensive suite of services to support the development of novel imaging probes for gastrointestinal and liver applications. We specialize in designing and validating MRI/CT contrast agents, radiotracers for PET/SPECT, fluorescent and photoacoustic nanoprobes, as well as microbubble contrast agents for ultrasound. Leveraging our imaging expertise and state-of-the-art facilities, we can characterize probe safety, pharmacokinetics and ability to detect diseases, helping customers quickly optimize probe performance.

What We Can Do for the Development of Diagnostic Tools and Technologies

In Vitro In Vivo

Comprehensive analytical validation to assess the sensitivity, specificity, and reproducibility of diagnostic tools.
Utilization of high-throughput omics technologies to explore molecular profiles in complex disease models.
Research and development capabilities in PCR, NGS, and microarray technologies for nucleic acid and protein biomarkers.
Implementation of physiologically relevant systems to test disease responses and evaluate drug effects.

Assessment of safety and toxicity through animal studies to ensure the reliability and suitability of diagnostic tools.
Evaluation of diagnostic accuracy using animal disease models to validate the effectiveness of the developed tools.
In vivo imaging techniques are employed in small and large animal models to visualize disease progression and response to treatment.
Correlation testing of diagnostic tool results with disease parameters, imaging data, and histology to validate their clinical relevance.
Conducting biocompatibility, pharmacokinetic, and dosage optimization tests to ensure the optimal performance and safety of the diagnostic tools.

Highlights of Our IVD Development Services

With expertise in immunology and immunochemistry, microbiology, cell culture, and manufacturing process development, we understand disease mechanisms in depth.
Our facilities are fully equipped to conjugate purified antigens or monoclonal antibodies with labels such as horseradish peroxidase (HRP), alkaline phosphatase (AP), avidin, or biotin.
Working side-by-side with Ace Therapeutics increases efficiency and reduces time, accelerating IVD product development and commercialization.

Whether you need assistance identifying novel diagnostic targets, developing sensitive detection methods, or conducting preclinical evaluation studies, Ace Therapeutics' interdisciplinary team can provide solutions across the diagnostic product development continuum. To discuss how we can apply our diagnostic tool development expertise and end-to-end services to support your goals, please contact us.

Our products and services are for research use only and can not be used for diagnostic or other purposes.